4.3 Letter

Implications for COVID-19 triage from the ICNARC report of 2204 COVID-19 cases managed in UK adult intensive care units

Journal

EMERGENCY MEDICINE JOURNAL
Volume 37, Issue 6, Pages 332-333

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/emermed-2020-209791

Keywords

assessment; general; triage; respiratory; intensive care

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

Vascular inflammation and endothelial injury in SARS-CoV-2 infection: the overlooked regulatory cascades implicated by the ACE2 gene cluster

C. L. Shovlin, M. P. Vizcaychipi

Summary: COVID-19 presents more systemic complications and severe pulmonary vasculopathy compared to other respiratory viruses, which may be related to the sustained downregulation of ACE2 protein expression after SARS-CoV-2 infection. Research has shown that the ACE2 gene is located in a novel cluster on the X chromosome that is co-regulated with other genes. Failure to rapidly suppress viral replication in patients predicts delayed responses that may contribute to deteriorations.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2023)

Letter Critical Care Medicine

Burns during the epidemic, what changed?

Asako Shida, Marcela Vizcaychipi

BURNS (2021)

Correction Critical Care Medicine

Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study (vol 47, pg 160, 2021)

Sonia O. Labeau, Elsa Afonso, Julie Benbenishty, Bronagh Blackwood, Carole Boulanger, Stephen J. Brett, Silvia Calvino-Gunther, Wendy Chaboyer, Fiona Coyer, Mieke Deschepper, Guy Francois, Patrick M. Honore, Radmilo Jankovic, Ashish K. Khanna, Mireia Llaurado-Serra, Frances Lin, Louise Rose, Francesca Rubulotta, Leif Saager, Ged Williams, Stijn I. Blot

INTENSIVE CARE MEDICINE (2021)

Article Geriatrics & Gerontology

Frailty is associated with long-term outcome in patients with sepsis who are over 80 years old: results from an observational study in 241 European ICUs

Lenneke E. M. Haas, Ariane Boumendil, Hans Flaatten, Bertrand Guidet, Mercedes Ibarz, Christian Jung, Rui Moreno, Alessandro Morandi, Finn H. Andersen, Tilemachos Zafeiridis, Sten Walther, Sandra Oeyen, Susannah Leaver, Ximena Watson, Carole Boulanger, Wojciech Szczeklik, Joerg C. Schefold, Maurizio Cecconi, Brian Marsh, Michael Joannidis, Yuriy Nalapko, Muhammed Elhadi, Jesper Fjolner, Antonio Artigas, Dylan W. de Lange

Summary: The study investigated the short- and long-term mortality of VIPs aged 80 and above admitted with sepsis, identifying age, disease severity, and frailty as predictors of long-term mortality.

AGE AND AGEING (2021)

Article Surgery

Inflammation Disrupts the Brain Network of Executive Function after Cardiac Surgery

Yangzi Zhu, Meiyan Zhou, Xiuqin Jia, Wei Zhang, Yibing Shi, Shengjie Bai, Sanketh Rampes, Marcela P. Vizcaychipi, Congyou Wu, Kai Wang, Daqing Ma, Qi Yang, Liwei Wang

Summary: The goal of this study was to investigate the changes in functional connectivity (FC) after cardiac surgery and its relationship with cognitive deficits and systemic inflammation. Seventeen patients who underwent cardiac valve replacement and age-matched healthy controls were included in the study. Results showed that executive function was significantly impaired after cardiac surgery. The surgical patients demonstrated decreased FC within the executive control network and attenuated negative connectivity in the default mode network, which were related to increased tumor necrosis factor-a levels and decreased executive function up to day 7 after surgery.

ANNALS OF SURGERY (2023)

Article Clinical Neurology

Ischemic Stroke in Patients With Pulmonary Arteriovenous Fistulas

Karan K. Topiwala, Smit D. Patel, Mubashir Pervez, Claire L. Shovlin, Mark J. Alberts

Summary: Pulmonary arteriovenous fistulas (PAVFs) are a treatable cause of acute ischemic stroke, possibly related to hereditary hemorrhagic telangiectasia. Patients with PAVF are younger, have lower inpatient morbidity and case fatality rates, and exhibit several independent risk markers for AIS.

STROKE (2021)

Article Genetics & Heredity

Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations

Srimmitha Balachandar, Tamara J. Graves, Anika Shimonty, Katie Kerr, Jill Kilner, Sihao Xiao, Richard Slade, Manveer Sroya, Mary Alikian, Emanuel Curetean, Ellen Thomas, Vivienne P. M. McConnell, Shane McKee, Freya Boardman-Pretty, Andrew Devereau, Tom A. Fowler, Mark J. Caulfield, Eric W. Alton, Teena Ferguson, Julian Redhead, Amy J. McKnight, Geraldine A. Thomas, Micheala A. Aldred, Claire L. Shovlin

Summary: Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant vascular dysplasia caused by mutations in ACVRL1, ENG, or SMAD4 genes. A novel GDF2 variant has been identified in HHT patients with pulmonary AVMs, suggesting a new association between GDF2 mutations and HHT.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2022)

Article Genetics & Heredity

The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care

C. L. Shovlin, E. Buscarini, C. Sabba, H. J. Mager, A. D. Kjeldsen, F. Pagella, U. Sure, S. Ugolini, P. M. Torring, P. Suppressa, C. Rennie, M. C. Post, M. C. Patel, T. H. Nielsen, G. Manfredi, G. M. Lenato, D. Lefroy, U. Kariholu, B. Jones, A. D. Fialla, O. F. Eker, O. Dupuis, F. Droege, N. Coote, E. Boccardi, A. Alsafi, S. Alicante, S. Dupuis-Girod

Summary: Hereditary haemorrhagic telangiectasia (HHT) is a complex vascular disease affecting 85,000 European citizens. The European Reference Network established a working group dedicated to HHT, providing expert care and treatment standards for HHT patients.

EUROPEAN JOURNAL OF MEDICAL GENETICS (2022)

Review Clinical Neurology

Ischemic Stroke and Pulmonary Arteriovenous Malformations

Karan K. Topiwala, Smit D. Patel, Jeffrey L. Saver, Christopher D. Streib, Claire L. Shovlin

Summary: Covert pulmonary arteriovenous malformations (PAVMs) have the potential to cause early onset, preventable ischemic strokes, occurring a decade earlier than routine strokes with high prevalence rates according to large-scale thoracic CT screens. Treatment options such as single antiplatelet therapy may be effective for secondary prophylaxis, but require nuanced risk-benefit analysis.

NEUROLOGY (2022)

Article Respiratory System

Pulmonary arteriovenous malformations may be the only clinical criterion present in genetically confirmed hereditary haemorrhagic telangiectasia

Emily Anderson, Lakshya Sharma, Ali Alsafi, Claire L. Shovlin

Summary: For patients with pulmonary arteriovenous malformations (PAVMs), enhanced clinical suspicion and genetic testing for hereditary hemorrhagic telangiectasia (HHT) is recommended, even in the absence of significant features of HHT.

THORAX (2022)

Article Hematology

Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation

Katie E. Joyce, Ebun Onabanjo, Sheila Brownlow, Fadumo Nur, Kike Olupona, Kehinde Fakayode, Manveer Sroya, Geraldine A. Thomas, Teena Ferguson, Julian Redhead, Carolyn M. Millar, Nichola Cooper, D. Mark Layton, Freya Boardman-Pretty, Mark J. Caulfield, Genomics England Res Consortium, Clarire L. Shovlin

Summary: Patients with HHT commonly have rare variants in genes relevant to their phenotype, offering new therapeutic targets and opportunities for personalized medicine strategies.

BLOOD ADVANCES (2022)

Article Genetics & Heredity

European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?

Sophie Dupuis-Girod, Claire L. Shovlin, Anette D. Kjeldsen, Hans-Jurgen Mager, Carlo Sabba, Freya Droege, Anne-Emmanuelle Fargeton, Annette D. Fialla, Silvia Gandolfi, Ruben Hermann, Gennaro M. Lenato, Guido Manfredi, Marco C. Post, Catherine Rennie, Patrizia Suppressa, Ulrich Sure, Elisabetta Buscarini

Summary: Hereditary haemorrhagic telangiectasia (HHT) is a rare vascular disease that causes nosebleeds, anemia, and organ malformations. The treatment for HHT is diverse, and one option is intravenous bevacizumab.

EUROPEAN JOURNAL OF MEDICAL GENETICS (2022)

Letter Hematology

MEK 1 inhibition and bleeding in hereditary haemorrhagic telangiectasia

Claire L. Shovlin, Dilip Patel, Adrianna Bielowka, Jonathan A. Ledermann, Atieh Modarresi, Maria E. Genomics England Res Consortium, Maria E. Bernabeu-Herrero, Micheala A. Aldred, Ali Alsafi

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Article Genetics & Heredity

Updates on diagnostic criteria for hereditary haemorrhagic telangiectasia in the light of whole genome sequencing of 'gene-negative' individuals recruited to the 100 000 Genomes Project

Claire L. Shovlin, Fatma Almaghlouth, Ali Alsafi, Nicola Coote, Catherine Rennie, Gillian M. F. Wallace, Fatima S. Govani, Genomics England Res Consortium

JOURNAL OF MEDICAL GENETICS (2023)

No Data Available